Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 212-977-2 | CAS number: 897-06-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Androstadiendion is negative with and without metabolic activation in a bacterial reverse mutation assay (Ames test) (Wollny, 1995). In addition, an Ames test (Reimann, 1996) and a HPRT assay in V79 cells (Wollny, 2013) revealed negeative results with the read-across substance androstendion.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- July 1995
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- yes
- Remarks:
- - only one experiment was performed
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- Histidine gene locus
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254 induced male rat liver S9 mix
- Test concentrations with justification for top dose:
- 33.3, 100, 333.3, 1000, 2500, 5000 µg/plate
- Vehicle / solvent:
- DMSO
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: without metabolic activation: Sodium azide, 4-Nitro-o-phenylenediamine, Methyl methane sulfonate; with metabolic activation: 2-Aminoanthracene
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- without metabolic activation: at 1000 µg/plate and above in strains TA 1535, TA 1537 and TA 102; with metabolic activation: at 5000 µg/plate in strain TA 1535 as well as at 1000 µg/plate and above in strains TA 1537 and TA 102
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
- Conclusions:
- Interpretation of results (migrated information):
negative - Executive summary:
The mutagenic potential of the test substance was evaluated in a Salmonella/microsome test with the S. typhimurium strains TA 98, TA 100, TA 102, TA 1535 and TA 1537 in the presence and absence of S9 mix according to OECD TG 471. Evidence of mutagenic activity was not seen up to the maximum recommended dose level of 5000 µg/plate. No substantial increases in revertant colony numbers of any of the five tester strains were observed at any dose level in the presence and absence of metabolic activation. There was also no tendency of higher mutation rates with increasing concentrations in the range below the generally acknowledged border of biological relevance. Therefore, the test substance was considered to be non-mutagenic in the Salmonella typhimurium reverse mutation assay.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- May to Aug 2013
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Version / remarks:
- (1997)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- mammalian cell gene mutation assay
- Target gene:
- HPRT locus
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- - Type and identity of media: MEM with supplements; for the selection of mutant cells the medium was supplemented with 11 µg/mL 6-thioguanine.
- Properly maintained: yes
- Periodically "cleansed" against high spontaneous background: yes
- Periodically checked for karyotype stability: yes
- Periodically checked for Mycoplasma contamination: yes - Metabolic activation:
- with and without
- Metabolic activation system:
- S9-Mix from the liver of phenobarbital/ß-naphthoflavone induced rats.
- Test concentrations with justification for top dose:
- Experiment I: treatment time 4 hours, with and without S9 mix 7.5, 15.0, 30.0, 60.0, 120.0, and 240.0 µg/mL
Experiment II: treatment time 4 hours, with S9 mix 7.5, 15.0, 30.0, 60.0, 120.0, 180.0, and 240.0 µg/mL; treatment time 24 hours, without S9 mix 1.89, 3.75, 7.5, 15.0, 30.0, 60.0, 90.0, and 120.0 µg/mL. - Vehicle / solvent:
- DMSO
- Justification for choice of solvent/vehicle: The solvent was chosen due to its solubility properties and its relative non-toxicity to the cell cultures. - Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: ethylmethanesulfonate (EMS; 1.2 mM), 7,12-dimethylbenzanthracene (DMBA; 4.3 µM)
- Remarks:
- EMS was used without and DMBA with metabolic activation
- Details on test system and experimental conditions:
- PRE-TEST: Test item concentrations ranged between 15.0 ¿g/mL and 1920 ¿g/mL in the pre-experiment. As result no relevant toxic effect occurred up to the maximum concentration tested with and without metabolic activation following 4 hour treatment. A transient reduction of the cloning efficiency to 44.1 % at 480 ¿g/mL without metabolic activation was judged as precipitation artefact rather than true cytotoxicity as the cloning efficiency was back to normal at higher concentrations. Following 24 hours treatment without metabolic activation cytotoxic effects occurred at 120 ¿g/mL and above.
METHOD OF APPLICATION: in medium
Approximately 1.5×10exp6 (single culture) and 5×102 cells (in duplicate) were seeded in plastic culture flasks. The cells were grown for 24 hours prior to treatment. After 24 hours the medium was replaced with serum-free medium containing the test item, either without S9 mix or with 50 ¿l/mL S9 mix. Concurrent solvent and positive controls were treated in parallel. After 4 hours this medium was replaced with complete medium following two washing steps with "saline G". In the second experiment the cells were exposed to the test item for 24 hours in complete medium, supplemented with 10 % FBS, in the absence of metabolic activation.
Three or four days after treatment 1.5×10exp6 cells per experimental point were sub-cultivated in 175 cm² flasks containing 30 mL medium. Following the expression time of 7 days five 80 cm² cell culture flasks were seeded with about 3 - 5×10exp5 cells each in medium containing 6-TG. Two additional 25 cm² flasks were seeded with approx. 500 cells each in non-selective medium to determine the viability.
The cultures were incubated at 37 °C in a humidified atmosphere with 1.5 % CO2 for about 8 days. The colonies were stained with 10 % methylene blue in 0.01 % KOH solution.
The stained colonies with more than 50 cells were counted. In doubt the colony size was checked with a preparation microscope.
DURATION
- Exposure duration: 4 hours
- Expression time (cells in growth medium): 7 days
- Selection time: 8 days
DETERMINATION OF CYTOTOXICITY
- Method: cloning efficiency - Evaluation criteria:
- A test item is classified as positive if it induces either a concentration-related increase of the mutant frequency or a reproducible and positive response at one of the test points. A test item producing neither a concentration-related increase of the mutant frequency nor a reproducible positive response at any of the test points is considered non-mutagenic in this system.
A positive response is described as follows: A test item is classified as mutagenic if it reproducibly induces a mutation frequency that is three times above the spontaneous mutation frequency at least at one of the concentrations in the experiment. The test item is classified as mutagenic if there is a reproducible concentration-related increase of the mutation frequency. Such evaluation may be considered also in the case that a threefold increase of the mutant frequency is not observed. However, in a case by case evaluation this decision depends on the level of the corresponding solvent control data. If there is by chance a low spontaneous mutation rate within the laboratory¿s historical control data range, a concentration-related increase of the mutations within this range has to be discussed. The variability of the mutation rates of solvent controls within all experiments of this study was also taken into consideration. - Statistics:
- A linear regression (least squares) was performed to assess a possible dose dependent increase of mutant frequencies.
- Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- No substantial and reproducible dose dependent increase of the mutation frequency was observed in both main experiments. Appropriate reference mutagens, used as positive controls, induced a distinct increase in mutant colonies and thus, showed the sensitivity of the test system and the activity of the metabolic activation system.
TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH and osmolarity: There was no relevant shift of pH and osmolarity of the medium even at the maximum concentration of the test item.
- Water solubility: The maximum concentration of the pre-experiments (1920 ¿g/mL) was based on the solubility properties of the test item in DMSO and aqueous medium.
- Precipitation: No precipitation of the test item was observed up to the maximum analyzable concentration in both main experiments. In the pre-experiments precipitation occurred at 120 ¿g/mL and above after 4 hours treatment with and without metabolic activation, and at 480 ¿g/mL and above following 24 hours treatment without metabolic activation.
ADDITIONAL INFORMATION ON CYTOTOXICITY:
Cytotoxic effects indicated by a relative cloning efficiency I or relative cell density below 50 % of the corresponding solvent control were noted at 120 ¿g/mL in the first main experiment without metabolic activation. In the presence of metabolic activation no cytotoxicity was observed at the maximum analyzable concentration of 120 ¿g/mL. At the next higher concentration of 240 ¿g/mL exceedingly severe cytotoxic effects precluded analysis of any data on mutagenicity. In the second experiment cytotoxicity as described above occurred at 180 ¿g/mL with and at 120 ¿g/mL without metabolic activation. The recommended cytotoxic range of approximately 10-20 % relative cloning efficiency I or relative cell density was covered with and without metabolic activation. - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
- Conclusions:
- negative
- Executive summary:
The test item did not induce substantial and reproducible dose dependent increase of the mutation frequency in a mammalian cell gene mutation assay (HPRT) according to OECD TG 476. In this assay two independent experiments were conducted with V79 cells being treated for either 4 hours with and without metabolic activation or 24 hours without metabolic activation. Appropriate reference mutagens, used as positive controls, induced a distinct increase in mutant colonies and thus, showed the sensitivity of the test system and the activity of the metabolic activation system. Therefore, the substance was considered to be non-mutagenic in the specified test.
Referenceopen allclose all
Distinct toxic effects, evidenced by a reduction in the number of revertants and a reduced background growth at 5000 µg/plate, occurred in strains TA 1535, TA 1537 and TA 102 without metabolic activation from 1000 µg/plate up to 5000 µg/plate. With metabolic activation toxic effects occurred in strain TA 1535 at 5000 µg/plate and in strain TA 1537 and TA 102 from 1000 up to 5000 µg/plate.
No substantial increases in revertant colony numbers of any of the five tester strains were observed following treatment with ZK 4947 at any concentration level, either in the presence or absence of metabolic activation (S9 mix). There was also no tendency of higher mutation rates with increasing concentrations in the range below the generally acknowledged border of biological relevance.
Appropriate control mutagens were used as positive controls. They showed a distinct increase in induced revertant colonies.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Description of key information
A micronucleus test in male rats revealed negative results with the read-across substance androstendion (NTP, 2010). A second micronucleus testin mice, in which androstenedion was administered by gavage for 3 months, were negative in males but judged to be equivocal in females due to a small increase (two-fold over background) in micronucleated normochromatic erythrocytes observed at the highest dose administered (50 mg/kg) (NTP, 2010).
Link to relevant study records
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study (supervised by NTP); published data without detailed documentation
- Qualifier:
- according to guideline
- Guideline:
- other: NTP laboratory health and safety guidelines
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Principles of method if other than guideline:
- The study was performed according to standard three-exposure protocol as described by Shelby et al., Environ. Mol. Mutagen. 21, 1993, 160-179.
Cited from report: "These are the basic guidelines for arriving at an overall assay result for assays performed by the National Toxicology Program. Statistical as well as biological factors are considered. For an individual assay, the statistical procedures for data analysis have been described in the preceding protocols. There have been instances, however, in which multiple aliquots of a chemical were tested in the same assay, and different results were obtained among aliquots and/or among laboratories. Results from more than one aliquot or from more than one laboratory are not simply combined into an overall result. Rather, all the data are critically evaluated, particularly with regard to pertinent protocol variations, in determining the weight of evidence for an overall conclusion of chemical activity in an assay. In addition to multiple aliquots, the in vitro assays have another variable that must be considered in arriving at an overall test result. In vitro assays are conducted with and without exogenous metabolic activation. Results obtained in the absence of activation are not combined with results obtained in the presence of activation; each testing condition is evaluated separately." The summary table in the Abstract of the Technical Report presents a result that represents a scientific judgement of the overall evidence for activity of the chemical in an assay. - GLP compliance:
- not specified
- Type of assay:
- micronucleus assay
- Species:
- rat
- Strain:
- Fischer 344
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Strain: F344/N
no further data in NTP TR 560 - Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: corn oil
- Details on exposure:
- Preliminary range-finding studies were performed. Factors affecting dose selection included chemical solubility and toxicity and the extent of cell cycle delay induced by androstenedione exposure.
- Duration of treatment / exposure:
- 3 days; The animals were killed 24 hours after the third dosing and bone marrow samples prepared.
- Frequency of treatment:
- three times at 24-hour interval
- Post exposure period:
- 24 hours
- Remarks:
- Doses / Concentrations:
312.5 and 625 mg/kg bw
Basis:
actual ingested
exposure: 3 days - No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- The positive control animals received injections of cyclophosphamide (15 or 25 mg/kg).
- Tissues and cell types examined:
- The animals were killed 24 hours after the third dosing, and blood smears were prepared from bone marrow cells obtained from the femurs. Air-dried smears were fixed and stained. 2000 polychromatic erythrocytes (PCEs; reticulocytes) were scored for the frequency of micronucleated cells in each of up to five animals per dose group. In addition, the percentage of PCEs among the total erythrocyte population in the bone marrow was scored for each dose group as a measure of toxicity.
- Evaluation criteria:
- In the micronucleus test, an individual trial is considered positive if the trend test P value is less than or equal to 0.025 or if the P value for any single dosed group is less than or equal to 0.025 divided by the number of dosed groups. A final call of positive for micronucleus induction is preferably based on reproducibly positive trials. Ultimately, the final call is determined by the scientific staff after considering the results of statistical analyses, the reproducibility of any effects observed, and the magnitudes of those effects.
- Statistics:
- The frequency of micronucleated cells among PCEs was analyzed by a statistical software package that tested for increasing trend over dose groups with a one-tailed Cochran-Armitage trend test, followed by pairwise comparisons between each dosed group and the control group (Integrated Laboratory Systems (ILS), Micronucleus Data Management and Statistical Analysis Software, Version 1.4. ILS, Inc., P.O. Box 13501, Research Triangle Park, NC 277071990, 1990). In the presence of excess binomial variation, as detected by a binomial dispersion test, the binomial variance of the Cochran-Armitage test was adjusted upward in proportion to the excess variation.
- Key result
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- In vivo, no significant increases in the frequencies of micronucleated PCEs (reticulocytes) were observed in bone marrow of male F344/N rats administered androstenedione (312.5 or 625 mg/kg) by gavage once daily for 3 days. No significant changes in the percentages of PCEs among total erythrocytes were seen in the rats, suggesting no androstenedione-associated toxicity in the bone marrow.
- Conclusions:
- negative
- Executive summary:
Cited from NTP-report:
"No significant increases in the frequencies of micronucleated polychromatic erythrocytes, indicators of chromosomal damage, were observed in bone marrow of male rats administered androstenedione by gavage once daily for 3 consecutive days."
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study (supervised by NTP); published data without detailed documentation
- Qualifier:
- according to guideline
- Guideline:
- other: NTP laboratory health and safety guidelines
- Principles of method if other than guideline:
- A detailed discussion of this assay is presented by MacGregor et al., Fundam. Appl. Toxicol. 14, 1990, 513-522.
Cited from report: "These are the basic guidelines for arriving at an overall assay result for assays performed by the National Toxicology Program. Statistical as well as biological factors are considered. For an individual assay, the statistical procedures for data analysis have been described in the preceding protocols. There have been instances, however, in which multiple aliquots of a chemical were tested in the same assay, and different results were obtained among aliquots and/or among laboratories. Results from more than one aliquot or from more than one laboratory are not simply combined into an overall result. Rather, all the data are critically evaluated, particularly with regard to pertinent protocol variations, in determining the weight of evidence for an overall conclusion of chemical activity in an assay. In addition to multiple aliquots, the in vitro assays have another variable that must be considered in arriving at an overall test result. In vitro assays are conducted with and without exogenous metabolic activation. Results obtained in the absence of activation are not combined with results obtained in the presence of activation; each testing condition is evaluated separately." The summary table in the Abstract of the Technical Report presents a result that represents a scientific judgement of the overall evidence for activity of the chemical in an assay. - GLP compliance:
- not specified
- Type of assay:
- micronucleus assay
- Species:
- mouse
- Strain:
- not specified
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
no further data in NTP TR 560 - Route of administration:
- oral: gavage
- Vehicle:
- methylcellulose
- Duration of treatment / exposure:
- 3 months
- Frequency of treatment:
- once daily
- Post exposure period:
- 24 hours
- Remarks:
- Doses / Concentrations:
1 to 50 mg/kg bw
Basis:
actual ingested
exposure: 3 month - No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- none
- Tissues and cell types examined:
- At the end of the 3-month toxicity study (see chapter repeated dose toxicity for further results), peripheral blood samples were obtained from male and female mice. Smears were immediately prepared and fixed in absolute methanol. The methanol-fixed slides were stained with acridine orange and coded. Slides were scanned to determine the frequency of micronuclei in 2000 normochromatic erythrocytes (NCEs) in each of five animals per dose group. In addition, the percentage of PCEs among the total erythrocyte population was determined as a measure of bone marrow toxicity.
- Evaluation criteria:
- In the micronucleus test, an individual trial is considered positive if the trend test P value is less than or equal to 0.025 or if the P value for any single dosed group is less than or equal to 0.025 divided by the number of dosed groups. A final call of positive for micronucleus induction is preferably based on reproducibly positive trials. Ultimately, the final call is determined by the scientific staff after considering the results of statistical analyses, the reproducibility of any effects observed, and the magnitudes of those effects.
- Statistics:
- The results were tabulated as the mean of the pooled results from all animals within a treatment group plus or minus the standard error of the mean. The frequency of micronucleated cells among NCEs was analyzed by a statistical software package that tested for increasing trend over dose groups with a one-tailed Cochran-Armitage trend test, followed by pairwise comparisons between each dosed group and the control group (Integrated Laboratory Systems (ILS), Micronucleus Data Management and Statistical Analysis Software, Version 1.4. ILS, Inc., P.O. Box 13501, Research Triangle Park, NC 277071990, 1990). In the presence of excess binomial variation, as detected by a binomial dispersion test, the binomial variance of the Cochran-Armitage test was adjusted upward in proportion to the excess variation.
- Key result
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- not applicable
- Key result
- Sex:
- female
- Genotoxicity:
- ambiguous
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- not applicable
- Additional information on results:
- Following 3 months of androstenedione administration (1 to 50 mg/kg) by gavage, no increase in the frequency of micronucleated NCEs was seen in peripheral blood samples from male B6C3F1 mice. In female mice, a small increase in the frequency of micronucleated NCEs was observed at the highest dose tested (50 mg/kg); although not significantly elevated above the vehicle control (P=0.0142), this increase resulted in a significant trend (P=0.001), and the test in female mice was judged to be equivocal.
No significant changes in the percentages of PCEs among total erythrocytes were seen in mice, suggesting no androstenedione-associated toxicity in the bone marrow. - Conclusions:
- equivocal
- Executive summary:
Cited from NTP report:
"Results of a peripheral blood erythrocyte micronucleus test in mice, in which androstenedione was administered by gavage for 3 months, were negative in males but judged to be equivocal in females due to a small increase (twofold over background) in micronucleated normochromatic
erythrocytes observed at the highest dose administered (50 mg/kg)."
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
The mutagenic potential of androstadiendion was evaluated in a Salmonella/microsome test with the S. typhimurium strains TA 98, TA 100, TA 102, TA 1535 and TA 1537 in the presence and absence of S9 mix according to OECD TG 471 (Wollny, 1995). Evidence of mutagenic activity was not seen up to the maximum recommended dose level of 5000 µg/plate. No substantial increases in revertant colony numbers of any of the five tester strains were observed at any dose level in the presence and absence of metabolic activation. There was also no tendency of higher mutation rates with increasing concentrations in the range below the generally acknowledged border of biological relevance. Therefore, the test substance was considered to be non-mutagenic in the Salmonella typhimurium reverse mutation assay. The structural analogue substance androstendion did also not show a mutagenic potential in an Ames test with the S. typhimurim strains TA 98, TA 100, TA 102, TA 1535 and TA 1537 (Reimann, 1996) when tested up to the highest recommended dose level of 5000 µg/plate in the absence or presence of metabolic activation (OECD TG 471).
For androstadiendion (CAS No. 897-06-3) no HPRT or MNT in vivo data are available. Therefore, HPRT and MNT in vivo data of androstendion (CAS No.63-05 -8) were used. A search for structure-analogue substances using the QSAR Toolbox 3.3.5 recommended androstendion as one out of 11 category substances for a read-across approach (for details see QSAR OECD Toolbox Report on Androstadiendion attached in chapter 7, Endpoint Summary: Toxicological information).
Androstendion did not induce a substantial or reproducible dose dependent increase of the mutation frequency in a mammalian cell gene mutation assay (HPRT) according to OECD TG 476 (Wollny, 2013). In this assay two independent experiments were conducted with V79 cells being treated for either 4 hours with and without metabolic activation or 24 hours without metabolic activation. The substance was considered to be non-mutagenic in the specified test.
In addition, no significant increases in the frequencies of micronucleated polychromatic erythrocytes - indicators of chromosomal damage - were observed in bone marrow of male rats administered androstenedion by gavage once daily for 3 consecutive days (NTP, 2010). Results of a peripheral blood erythrocyte micronucleus test in mice, in which androstenedion was administered by gavage for 3 months, were negative in males but judged to be equivocal in females due to a small increase (two-fold over background) in micronucleated normochromatic erythrocytes observed at the highest dose administered (50 mg/kg) (NTP, 2010).
In summary, both androstendion and androstadiendion are considered to be non-genotoxic based on in vitro (Ames, HPRT) and in vivo (MNT) genotoxicity studies.
Justification for classification or non-classification
Based on the study results with androstadiendion and the read-across substance androstendion a classification according to Regulation (EC) No. 1272/2008 (CLP) is not required.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.